Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes
about
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusionDrug interactions--principles, examples and clinical consequencesDilemmas of the causality assessment tools in the diagnosis of adverse drug reactionsMonitoring medicines use: the role of the clinical pharmacologistCan knowledge of germline markers of toxicity optimize dosing and efficacy of cancer therapy?Predicting adverse drug reactions in older adults; a systematic review of the risk prediction modelsStem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet?Risk Factors Associated with the Requirement for Pharmaceutical Intervention in the Hospital Setting: A Systematic Review of the LiteratureOpioid-induced respiratory depression: reversal by non-opioid drugsDevelopment of the Liverpool Adverse Drug Reaction Avoidability Assessment ToolDevelopment and inter-rater reliability of the Liverpool adverse drug reaction causality assessment toolPercentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions--a meta-analysisReal time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort studyPrevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adultsApproaches to recording drug allergies in electronic health records: qualitative studyMedication monitoring in a nurse-led respiratory outpatient clinic: pragmatic randomised trial of the West Wales Adverse Drug Reaction ProfileDrug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective studyRare, serious, and comprehensively described suspected adverse drug reactions reported by surveyed healthcare professionals in UgandaIncidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatientsDRUG-DRUG INTERACTION PROFILES OF MEDICATION REGIMENS EXTRACTED FROM A DE-IDENTIFIED ELECTRONIC MEDICAL RECORDS SYSTEMQatar pharmacists' understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care.Capture and documentation of coded data on adverse drug reactions: an overview.Incidence, characteristics and risk factors of adverse drug reactions in hospitalized children - a prospective observational cohort study of 6,601 admissions.Identification of adverse drug events: the use of ICD-10 coded diagnoses in routine hospital data.Need for involving consumers in Nepal's pharmacovigilance systemA Qualitative Study of Knowledge, Attitude and Practice towards Pharmacovigilance among Doctors and Nursing Staff in a Tertiary Care Hospital in India.Good prescribing: better systems and prescribers needed.Drug-related admissions and hospital-acquired adverse drug events in Germany: a longitudinal analysis from 2003 to 2007 of ICD-10-coded routine dataInterpreting adverse drug reaction (ADR) reports as hospital patient safety incidents.Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults.Emergency re-admissions to hospital due to adverse drug reactions within 1 year of the index admissionThe use of opioids at the end of life: knowledge level of pharmacists and cooperation with physiciansAdverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital.Identifying genomic and developmental causes of adverse drug reactions in children.A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care settingDrug induced interstitial lung disease.The continuing challenge of providing drug information services to diminish the knowledge--practice gap in medical practice.An educational intervention's effect on healthcare professionals' attitudes towards pharmacovigilance.Adverse drug events identified by triggers at a teaching hospital in Brazil.Different black box warning labeling for same-class drugs.
P2860
Q24273350-3537F4D7-787F-4003-B331-F9463E2B089AQ24599421-E7DDE618-5E58-46D8-80FA-FBC5DF4C04F1Q26743858-8F6FF86B-770A-4CC0-A3F7-16E4AECE3E64Q26829859-C6D25749-B52E-44CA-BDDB-3E5D453E86E2Q26859144-60ED388B-FB57-4720-B482-B6009E6C26A7Q27006081-916FF5D7-9C4B-4B51-92B5-CB8289111187Q27024267-8DE55B37-D7E2-4586-A625-FB1D2A3F4E84Q28075471-82E699E9-A838-42CF-8FC6-0A71599A1E08Q28250265-FCE692A0-AF2F-48CB-A89F-4FA218F79C18Q28468439-D54E38E8-A7B3-43B8-863C-FF9C87EF4426Q28478391-BA105CDC-AA20-4104-B951-E93848982FD5Q28481506-9A5C14EA-BBB2-47C3-92F9-E16C4BFBD966Q28482250-D68832D8-CD64-4256-891D-2865ADEE0E20Q28536709-F7AF4F92-DC0D-41B5-8737-E807A479652FQ28537940-F37226F1-135E-45A6-BE02-9C8E4547C9D2Q28538501-A8C7863A-8144-410C-B5C5-48186DC2CB8FQ28539178-ECD3C918-34BF-4F7F-B4EC-7E45F5BDC752Q28546673-B1E2EF0E-E912-41BF-B89F-2CBC5C644443Q28559384-006201E4-EE5E-455F-BD2F-65A0776A8368Q28828695-3358B253-AA54-4674-B9E5-F6A92EF6D5F7Q30383466-B88185F8-75BA-4277-99A8-7475116F1928Q30632497-C214A212-959C-4EF8-8AB4-0C0ED0915BFFQ31143856-123ABA1A-C997-4FBF-A379-23C8D4026FDCQ33530079-B4FEFFD6-0E84-420E-8B97-BDA431D093C2Q33565507-22132815-B99E-4A67-AAE1-E9546445D528Q33741643-C6336E41-F224-48F6-ACF7-0B9ED9C1368DQ33753795-8F8EF199-36D4-4408-94D0-E7DECDAC84BDQ33914501-61F2FB35-F190-41E1-A4E0-A4D3CEEA2C2BQ34019363-E162770C-E551-42D7-B567-DFD06B3008AAQ34209590-F48A91F9-663D-4358-8767-7805D4B6FCC2Q34381378-E3ECF166-2E58-45C5-B73C-4E65571AFDD5Q34467712-8AACB4EB-3C75-45ED-9DAB-B7D0B6D589F1Q34509390-D40447CB-E763-4C5B-8D68-13DC321CCB61Q34603032-CDCB17E8-3397-4380-8DB5-F346B8A19F55Q34637462-26AF0E7E-D1D5-43A7-BD2E-A711EB679015Q34641494-7E7AA29F-1DFF-40FB-B1EB-571E0457BF61Q34703735-635A7556-3CF1-4730-92C6-4489EA835CA3Q34862636-0CABE03F-AC74-4E3B-A468-603CE9EAC10DQ34911147-9C0A13EE-A389-453D-AC42-FEC8D95F279CQ35007039-4E82F9A3-2CC9-4393-B9F4-348C6FD15D85
P2860
Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Adverse drug reactions in hosp ...... lysis of 3695 patient-episodes
@ast
Adverse drug reactions in hosp ...... lysis of 3695 patient-episodes
@en
Adverse drug reactions in hosp ...... lysis of 3695 patient-episodes
@nl
type
label
Adverse drug reactions in hosp ...... lysis of 3695 patient-episodes
@ast
Adverse drug reactions in hosp ...... lysis of 3695 patient-episodes
@en
Adverse drug reactions in hosp ...... lysis of 3695 patient-episodes
@nl
prefLabel
Adverse drug reactions in hosp ...... lysis of 3695 patient-episodes
@ast
Adverse drug reactions in hosp ...... lysis of 3695 patient-episodes
@en
Adverse drug reactions in hosp ...... lysis of 3695 patient-episodes
@nl
P2093
P2860
P3181
P1433
P1476
Adverse drug reactions in hosp ...... lysis of 3695 patient-episodes
@en
P2093
Christopher F Green
David R Mottram
Emma C Davies
Stephen Taylor
P2860
P3181
P356
10.1371/JOURNAL.PONE.0004439
P407
P577
2009-01-01T00:00:00Z